A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.
Li J, Wang Z, Zhong H, He Y, Zhang C, Niu Z, Yang S, Zhang T, Zhu L, Shu Y, Gao Y, Peng J, Song Y, Li J, Yuan Y, Zhang H, Yu G, Hua Y, Xiao J, Fu J, Zheng Y, Xue H, Luo X, Shi M, Su W, Qin S.
Li J, et al. Among authors: shi m.
Oncologist. 2024 Apr 20:oyae073. doi: 10.1093/oncolo/oyae073. Online ahead of print.
Oncologist. 2024.
PMID: 38642091
Free article.